BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 28360030)

  • 1. Old and new models for studying host-microbe interactions in health and disease:
    Young VB
    Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G623-G627. PubMed ID: 28360030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and functional changes within the gut microbiota and susceptibility to Clostridium difficile infection.
    Ross CL; Spinler JK; Savidge TC
    Anaerobe; 2016 Oct; 41():37-43. PubMed ID: 27180006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridium difficile colitis: pathogenesis and host defence.
    Abt MC; McKenney PT; Pamer EG
    Nat Rev Microbiol; 2016 Oct; 14(10):609-20. PubMed ID: 27573580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling infectious diseases and host-microbe interactions in gastrointestinal organoids.
    Bartfeld S
    Dev Biol; 2016 Dec; 420(2):262-270. PubMed ID: 27640087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of microbial derived secondary bile acids on colonization resistance against Clostridium difficile in the gastrointestinal tract.
    Winston JA; Theriot CM
    Anaerobe; 2016 Oct; 41():44-50. PubMed ID: 27163871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to Manipulate the Microbiota: Fecal Microbiota Transplantation.
    Fuentes S; de Vos WM
    Adv Exp Med Biol; 2016; 902():143-53. PubMed ID: 27161356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New perspectives in Clostridium difficile disease pathogenesis.
    Monaghan TM
    Infect Dis Clin North Am; 2015 Mar; 29(1):1-11. PubMed ID: 25573674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bloom and bust: intestinal microbiota dynamics in response to hospital exposures and Clostridium difficile colonization or infection.
    Vincent C; Miller MA; Edens TJ; Mehrotra S; Dewar K; Manges AR
    Microbiome; 2016 Mar; 4():12. PubMed ID: 26975510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gut microbiome in health and in disease.
    Shreiner AB; Kao JY; Young VB
    Curr Opin Gastroenterol; 2015 Jan; 31(1):69-75. PubMed ID: 25394236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Clostridium difficile infection: inhibition of NHE3 and microbiota profile.
    Engevik MA; Engevik KA; Yacyshyn MB; Wang J; Hassett DJ; Darien B; Yacyshyn BR; Worrell RT
    Am J Physiol Gastrointest Liver Physiol; 2015 Mar; 308(6):G497-509. PubMed ID: 25552580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Use of Defined Microbial Communities To Model Host-Microbe Interactions in the Human Gut.
    Elzinga J; van der Oost J; de Vos WM; Smidt H
    Microbiol Mol Biol Rev; 2019 May; 83(2):. PubMed ID: 30867232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectious disease. Adapting Koch's postulates.
    Byrd AL; Segre JA
    Science; 2016 Jan; 351(6270):224-6. PubMed ID: 26816362
    [No Abstract]   [Full Text] [Related]  

  • 13. Clostridium difficile recurrent infection: possible implication of TA systems.
    Gil F; Pizarro-Guajardo M; Álvarez R; Garavaglia M; Paredes-Sabja D
    Future Microbiol; 2015; 10(10):1649-57. PubMed ID: 26439907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Building the microbiome in health and disease: niche construction and social conflict in bacteria.
    McNally L; Brown SP
    Philos Trans R Soc Lond B Biol Sci; 2015 Aug; 370(1675):. PubMed ID: 26150664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Clostridium difficile infection: altered mucus production and composition.
    Engevik MA; Yacyshyn MB; Engevik KA; Wang J; Darien B; Hassett DJ; Yacyshyn BR; Worrell RT
    Am J Physiol Gastrointest Liver Physiol; 2015 Mar; 308(6):G510-24. PubMed ID: 25552581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human gut microbiome as source of innovation for health: Which physiological and therapeutic outcomes could we expect?
    Doré J; Multon MC; Béhier JM;
    Therapie; 2017 Feb; 72(1):21-38. PubMed ID: 28131442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of fungi in C. difficile infection: An underappreciated transkingdom interaction.
    Stewart D; Romo JA; Lamendella R; Kumamoto CA
    Fungal Genet Biol; 2019 Aug; 129():1-6. PubMed ID: 30978391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal Microbiota in Animal Models of Inflammatory Diseases.
    Hörmannsperger G; Schaubeck M; Haller D
    ILAR J; 2015; 56(2):179-91. PubMed ID: 26323628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium difficile infection and intestinal microbiota interactions.
    Rodriguez C; Taminiau B; Van Broeck J; Delmée M; Daube G
    Microb Pathog; 2015 Dec; 89():201-9. PubMed ID: 26549493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut biogeography of the bacterial microbiota.
    Donaldson GP; Lee SM; Mazmanian SK
    Nat Rev Microbiol; 2016 Jan; 14(1):20-32. PubMed ID: 26499895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.